Form 4: PDS Biotechnology Corp Director Iliev Ilian Acquires 9,000 Stock Options
SEC Form 4 Filing
Director Iliev Ilian of PDS Biotechnology Corp reports acquiring 9,000 stock options on June 24, 2024.
Summary
- On June 24, 2024, Iliev Ilian, a director of PDS Biotechnology Corp, acquired 9,000 employee stock options.
- The exercise price of these options is $2.86.
- The options vest fully on the first anniversary of the grant date, contingent upon continued service as a director.
- The options expire on June 24, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock option grants, and does not inherently convey positive or negative sentiment.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC filing related to insider transactions. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of the shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/24/2024 | Date of earliest transaction: Iliev Ilian acquired 9,000 stock options. |
| 06/24/2025 | Stock options vest in full, subject to continued service as a director. |
| 06/24/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.